| Not Yet Recruiting | Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma NCT07303283 | Kai Hu | Phase 2 |
| Not Yet Recruiting | Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients NCT07247201 | Singapore General Hospital | Phase 1 / Phase 2 |
| Recruiting | Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC NCT07459296 | First Affiliated Hospital of Guangxi Medical University | Phase 3 |
| Recruiting | Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma NCT06796270 | The Second Affiliated Hospital of Hainan Medical University | N/A |
| Not Yet Recruiting | Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasop NCT07388758 | Sun Yat-sen University | Phase 2 |
| Recruiting | Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial NCT07340515 | Man Hu | Phase 3 |
| Not Yet Recruiting | A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in th NCT07252375 | Fujian Cancer Hospital | Phase 2 |
| Recruiting | Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngea NCT07328841 | Ming-Yuan Chen | Phase 3 |
| Recruiting | Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatme NCT07101744 | Sun Yat-sen University | Phase 2 |
| Recruiting | Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasophary NCT07277764 | Jiangxi Provincial Cancer Hospital | Phase 2 |
| Not Yet Recruiting | Molecular Research on Predictive Efficacy and New Therapeutic Targets for Nasopharyngeal Carcinoma NCT07198802 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Not Yet Recruiting | Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar NCT07137052 | The First Affiliated Hospital of Xiamen University | — |
| Recruiting | SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC NCT06982300 | University Medical Center Groningen | Phase 1 / Phase 2 |
| Recruiting | Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC NCT07303023 | Fudan University | Phase 3 |
| Not Yet Recruiting | Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcin NCT07136519 | Affiliated Hospital of Guangdong Medical University | Phase 2 |
| Recruiting | Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Meta NCT07188584 | Ming-Yuan Chen | Phase 3 |
| Not Yet Recruiting | Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma NCT07064902 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm C NCT06987123 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma NCT06900218 | Sun Yat-sen University | Phase 3 |
| Recruiting | A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or In NCT06839066 | Shanghai Henlius Biotech | Phase 2 |
| Recruiting | Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma NCT06712888 | Sun Yat-sen University | Phase 3 |
| Not Yet Recruiting | KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical NCT06752473 | Kousai Bio Co., Ltd. | EARLY_Phase 1 |
| Recruiting | An International Study on Pediatric Patients With Rare Tumors. NCT07072143 | Azienda Ospedaliera di Padova | — |
| Recruiting | Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyng NCT06870435 | Ming-Yuan Chen | N/A |
| Enrolling By Invitation | Prognostic Value of TIL in Nasopharyngeal Carcinoma NCT06763640 | Jiangxi Provincial Cancer Hospital | — |
| Recruiting | Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma NCT07085988 | Jiangxi Provincial Cancer Hospital | Phase 2 |
| Recruiting | Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and NCT06763289 | First Affiliated Hospital, Sun Yat-Sen University | — |
| Not Yet Recruiting | Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinom NCT06695936 | Sun Yat-sen University | — |
| Active Not Recruiting | "Xijiang Project" Screening Cohort for NPC NCT06787456 | Ming-Yuan Chen | — |
| Not Yet Recruiting | Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage Ta NCT06680115 | First Affiliated Hospital of Guangxi Medical University | Phase 2 |
| Recruiting | Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyn NCT06611150 | Sun Yat-sen University | Phase 1 |
| Active Not Recruiting | Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy Alone NCT06612697 | Taichung Veterans General Hospital | — |
| Completed | Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma NCT06676293 | Chang Gung Memorial Hospital | N/A |
| Active Not Recruiting | Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Thei NCT07011329 | Hubei Cancer Hospital | — |
| Recruiting | Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma NCT07327216 | Affiliated Hospital of Guangdong Medical University | Phase 3 |
| Completed | Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advance NCT04215978 | BeiGene | Phase 1 |
| Active Not Recruiting | Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in China NCT07088861 | Lirong Wu | — |
| No Longer Available | Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignan NCT02822495 | Atara Biotherapeutics | — |